IMIDomics Team

Multidisciplinary team experienced in creating the platform and applying insights from it to improve treatment of IMIDs.


Leadership

card image

Sara Marsal, MD, PhD

Founder & Chief Medical Officer Board Director (Vall d’Hebron University Hospital, Professor of Rheumatology UAB)

card image

Richard M. Myers, PhD

Founder & Chief Scientific Advisor (HudsonAlpha Institute for Biotechnology, Stanford, UCSF, Harvard University)

card image

Toni Julià, PhD

Chief Data Scientist
(Vall d’Hebron University Hospital)

card image

Manuel López-Figueroa, PhD

Chief Operating Advisor Board Director
(Bay City Capital, Pritzker Consortium, UMICH., U. Copenhagen)

card image

Sandy Zweifach

Board Director
(Nuvelution, Bay City Capital, Pathways Diagnostics)

card image

Michael Stocum

Strategic Business Advisor (Inivata, Personalized Medicine Partners, GSK, Organon Teknika)

card image

Juan Harrison

Strategic Business Advisor
(Takeda, Xenoport, Powderject, Alza)

card image

Fred Craves, PhD

Board Director
(Bay City Capital, Berlex, Reliant, Medarex, Incyte, Madrigal)